Malaria vaccines put to the test: can three new shots trigger protection?
Vaccine
Not yet recruiting
Researchers are testing three experimental malaria vaccines (LYB014, LYB017, and LYB027) in healthy adults aged 18 to 50. Participants receive either a low or high dose of one vaccine combined with an immune-boosting adjuvant, or the adjuvant alone as a comparison. The trial trac…
Phase 1 • Sponsor: Guangzhou Patronus Biotech Co., Ltd. • Aim: Vaccine
Last updated Sep 21, 2026 21:00 UTC